Oxolam (Ciclopirox Olamine)

Ciclopirox olamine, the active ingredient in Oxolam, is an antifungal presented as a topical formulation for dermal use. It treats superficial fungal infections such as athlete's foot, jock itch and ringworm in adults and children. GNH USA supplies Oxolam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

GNH USA supplies Oxolam as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Oxolam is an antifungal agent that is applied to treat infections of the skin and its appendages.

- Athlete’s foot (tinea tarsalis): reduces fungal growth and relieves itching and scaling. - Jock itch (tinea cruris): eliminates the causative dermatophytes and improves skin comfort. - Ringworm (tinea corporea): clears the infection and promotes healing of lesions. - Seborrheic dermatitis: helps control Malassezia‑related flaking and redness. - Onychomycosis (nail fungus): supports gradual clearance of fungal elements from the nail plate.

Adverse reactions to Oxolam are generally mild and limited to the site of application.

Common Side Effects: - Local burning or stinging sensation. - Mild itching or erythema. - Dryness or peeling of the treated skin. - Contact dermatitis in sensitive individuals.

Serious or Rare Side Effects: - Severe allergic reaction (angio‑edema, anaphylaxis). - Extensive skin blistering or ulceration. - Persistent worsening of the infection despite therapy. - Systemic hypersensitivity manifestations such as fever or lymphadenopathy.

When using Oxolam, follow these safety guidelines:

- Application frequency: adhere to the prescribed number of applications per day. - Treatment duration: complete the full course even if symptoms improve. - Skin integrity: avoid use on severely damaged or inflamed skin unless directed by a clinician. - Concomitant topical agents: do not combine with other medicated creams without professional advice. - Pediatric use: consult a healthcare professional before treating children under the recommended age. - Store at ambient temperature: keep in the original packaging, protect from moisture and direct sunlight.

Oxolam has a low potential for systemic drug interactions, but caution is advised in the following situations:

Major Interactions (Avoid): - Concurrent use with other topical antifungals containing the same active ingredient, which may increase local irritation.

Moderate Interactions (Monitor Closely): - Application over skin pre‑treated with corticosteroids, which can alter absorption. - Use together with photosensitizing agents, increasing risk of phototoxic reactions. - Co‑administration with occlusive dressings that trap moisture and enhance drug penetration. - Combination with systemic antifungal therapy, requiring monitoring for overlapping toxicity. - Use on extensive body surface areas, which may raise systemic exposure.